We are recruiting a driven and passionate Delivery Scientist keen to use their knowledge in a commercial setting on a 12 month fixed term contract. The role will focus on delivering client projects, performing established assays, and ensuring accurate and timely communication of data.
About Magnitude Biosciences
Magnitude Biosciences Ltd is a specialist contract research organisation delivering C. elegans solutions to the biotechnology, pharmaceutical and nutraceutical industries. We are a team of multidisciplinary experts who combine our C. elegans expertise, unique automated assays, and novel patented healthspan imaging system (WormGazer™) to provide bespoke solutions for our clients.
Our novel WormGazer™ imaging technology continuously monitors worm movement automatically, providing data on growth and development, healthspan and quantifiable data in behavioural assays. Our assays are designed to deliver solutions for understanding mode of action for compounds and other interventions, understanding toxicity, supporting drug discovery in biotech and testing novel food ingredients for potential health benefits.
At Magnitude Biosciences you will enjoy a good work-life balance, supportive team and the opportunity to grow your skills and responsibilities in new areas. The role is full time, on site in NETPark, Sedgefield, County Durham, UK.
About the Role
The post holder will work closely with our other Research Scientists and report to the Head of Lab. Appropriate training will be provided.
Essential Criteria
Desirable criteria
Hours: 35 per week
The salary will be appropriate for the skills and experience of the successful candidate.
Application
Please send your application including a statement of why you are suitable for the job, how you fit the job criteria and your CV to careers@magnitudebiosciences.com
Deadline: 12 August 2024
Job Types: Full-time, Temporary contract
Contract length: 12 months
Pay: £21,000.00-£25,000.00 per year
Benefits:
Schedule: Monday to Friday
Work Location: In person
Application deadline: 12/08/2024
Sign up to our newsletter today, to get access to the latest company and industry news